Template:Percutaneous Coronary Intervention: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
No edit summary |
||
Line 73: | Line 73: | ||
:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI in Specific Clinical Situations|PCI in Specific Clinical Situations:]] | :[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI in Specific Clinical Situations|PCI in Specific Clinical Situations:]] | ||
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Patients With Asymptomatic Ischemia or CCS Class I or II Angina|PCI in patients with Asymptomatic Ischemia or CCS Class I or II Angina]] | |||
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Patients With CCS Class III Angina|PCI in patients with CCS Class III Angina]] | |||
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI in patients with Unstable Angina/Non–ST-Elevation Myocardial Infarction|PCI in patients with Unstable Angina/Non–ST-Elevation Myocardial Infarction]] | ::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI in patients with Unstable Angina/Non–ST-Elevation Myocardial Infarction|PCI in patients with Unstable Angina/Non–ST-Elevation Myocardial Infarction]] | ||
Line 82: | Line 86: | ||
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Primary PCI of the Infarct Artery|Primary PCI of the Infarct Artery]] | :::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Primary PCI of the Infarct Artery|Primary PCI of the Infarct Artery]] | ||
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Delayed or Elective PCI in | :::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Delayed or Elective PCI in Patients with STEMI|Delayed or Elective PCI in patients with STEMI]] | ||
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Patients With STEMI: General and Specific Considerations|STEMI: General and Specific Considerations]] | |||
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI in Fibrinolytic-Ineligible Patients|PCI in Fibrinolytic-Ineligible Patients]] | |||
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Facilitated PCI|Facilitated PCI]] | |||
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Rescue PCI (PCI After Failed Fibrinolysis)|Rescue PCI]] | |||
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI After Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion|PCI After Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion]] | |||
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI in patients with Cardiogenic Shock|PCI in patients with Cardiogenic Shock]] | ::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI in patients with Cardiogenic Shock|PCI in patients with Cardiogenic Shock]] | ||
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI in patients with Prior Coronary Bypass Surgery|PCI in patients with Prior Coronary Bypass Surgery]] | |||
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Revascularization Before Non-cardiac Surgery|Revascularization Before Non-cardiac Surgery]] | ::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Revascularization Before Non-cardiac Surgery|Revascularization Before Non-cardiac Surgery]] | ||
Line 90: | Line 106: | ||
:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Coronary Stents|Coronary Stents]] | :[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Coronary Stents|Coronary Stents]] | ||
:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines# | :Adjunctive Diagnostic Devices: | ||
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Fractional Flow Reserve|Fractional Flow Reserve]] | |||
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Intravascular Ultrasound|Intravascular Ultrasound]] | |||
:Adjunctive Therapeutic Devices: | |||
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Coronary Atherectomy|Coronary Atherectomy]] | ::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Coronary Atherectomy|Coronary Atherectomy]] | ||
Line 102: | Line 124: | ||
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Embolic Protection Devices|Embolic Protection Devices]] | ::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Embolic Protection Devices|Embolic Protection Devices]] | ||
:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Percutaneous Hemodynamic Support Devices|Percutaneous Hemodynamic Support Devices | :[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Percutaneous Hemodynamic Support Devices|Percutaneous Hemodynamic Support Devices]] | ||
:Antiplatelet Therapy: | |||
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Oral Antiplatelet Therapy|Oral Antiplatelet Therapy]] | ::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Oral Antiplatelet Therapy|Oral Antiplatelet Therapy]] | ||
:: | ::Intravenous Antiplatelet Therapy: | ||
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Intravenous Antiplatelet Therapy | :::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Intravenous Antiplatelet Therapy: ST-Elevation Myocardial Infarction (STEMI)|STEMI]] | ||
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Intravenous Antiplatelet Therapy | :::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Intravenous Antiplatelet Therapy: Unstable Angina / Non-ST Elevation Myocardial Infarction (UA/NSTEMI)|UA/NSTEMI]] | ||
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Intravenous Antiplatelet Therapy | :::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Intravenous Antiplatelet Therapy: Sudden Ischemia Heart Disease (SIHD)|SIHD]] | ||
: | :Anticoagulant Therapy: | ||
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Use of Parenteral Anticoagulants | :::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Use of Parenteral Anticoagulants during PCI|Parenteral Anticoagulants During PCI]] | ||
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Unfractionated Heparin|Unfractionated Heparin]] | :::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Unfractionated Heparin|Unfractionated Heparin]] | ||
Line 122: | Line 146: | ||
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Enoxaparin|Enoxaparin]] | :::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Enoxaparin|Enoxaparin]] | ||
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Bivalirudin and | :::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Bivalirudin and Argatoban|Bivalirudin and Argatroban]] | ||
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Fondaparinux|Fondaparinux]] | :::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Fondaparinux|Fondaparinux]] | ||
Line 128: | Line 152: | ||
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#No-Reflow Pharmacological Therapies|No-Reflow Pharmacological Therapies]] | ::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#No-Reflow Pharmacological Therapies|No-Reflow Pharmacological Therapies]] | ||
: | :PCI in Specific Anatomic Situations: | ||
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Chronic Total Occlusions|Chronic Total Occlusions]] | ::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Chronic Total Occlusions|Chronic Total Occlusions]] | ||
Line 140: | Line 164: | ||
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Calcified Lesions|Calcified Lesions]] | ::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Calcified Lesions|Calcified Lesions]] | ||
: | :PCI in Specific Patient Populations: | ||
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Chronic Kidney Disease|Chronic Kidney Disease]] | ::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Chronic Kidney Disease|Chronic Kidney Disease]] | ||
:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines# | :[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Peri-procedural Myocardial Infarction Assessment|Peri-procedural Myocardial Infarction Assessment]] | ||
:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Vascular Closure Devices|Vascular Closure Devices]] | :[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Vascular Closure Devices|Vascular Closure Devices]] | ||
Line 156: | Line 180: | ||
:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Post-procedural Antiplatelet Therapy|Post-procedural Antiplatelet Therapy:]] | :[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Post-procedural Antiplatelet Therapy|Post-procedural Antiplatelet Therapy:]] | ||
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Proton Pump Inhibitors and | ::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Proton Pump Inhibitors and Anti-platelet Therapy|Proton Pump Inhibitors and Antiplatelet Therapy]] | ||
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Clopidogrel Genetic Testing|Clopidogrel Genetic Testing]] | ::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Clopidogrel Genetic Testing|Clopidogrel Genetic Testing]] |
Revision as of 16:59, 19 December 2011
Percutaneous Coronary Intervention Microchapters |
Guideline Recommendations |
---|
CAD Revascularization: |
Pre-procedural Considerations: |
Procedural Considerations:
|
Post-Procedural Considerations: |
Quality and Performance Considerations: |
Percutaneous Coronary Intervention On the Web |
American Roentgen Ray Society Images of Percutaneous Coronary Intervention |
Directions to Hospitals Treating Percutaneous Coronary Intervention |
Risk calculators and risk factors for Percutaneous Coronary Intervention |